More News
HEALTHCARE | Staff Reporter, Singapore
view(s)

QT Vascular clinches full FDA approval to begin drug-coated balloon testing

Patient enrollment will begin early next year.

SGX-listed QT Vascular has been granted the full approval by the Food and Drug Administration to begin enrolling patients in the pivotal study of its new drug-coated balloon, known as Chocolate Touch.

The full IDE approval allows for enrollment up to 585 patients and up to 50 centers in the United States while additional patients may be enrolled in selected centers outside the US.
 

Do you know more about this story? Contact us anonymously through this link.

Click here to learn about advertising, content sponsorship, events & rountables, custom media solutions, whitepaper writing, sales leads or eDM opportunities with us.

To get a media kit and information on advertising or sponsoring click here.